Clinical trial
Calcium Channel Blocker in Myotonic Dystrophy Type 1 (CAP DM1)
NCT07075965 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Calcium Channel Blocker in Myotonic Dystrophy Type 1 (CAP DM1)
- Lead sponsor
- University of Rochester
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- December 7, 2026
- Completion date
- October 1, 2030
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
myotonic dystrophy 1